Hypogonadism
Navigation Links
Hypogonadism in Medical News
...
Although testosterone levels decline with age, hypogonadism is not a natural consequence of the aging process. "Men with clinically diagnosed hypogonadism do not need to 'tolerate' the symptoms of low ... by Bayer Schering Pharma AG.
ABOUT hypogonadism
Hypogonadism, also known as low ...
... new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone ... at Harvard Medical School . "But treating hypogonadism can result in significant health benefits for ... Morgentaler noted: "Because men who suffer from hypogonadism need to remain on treatment for life, it is very ...
... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...
... new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone ... at Harvard Medical School . "But treating hypogonadism can result in significant health benefits for ... Morgentaler noted: "Because men who suffer from hypogonadism need to remain on treatment for life, it is very ...
New recommendations by scientific societies about late-onset hypogonadism
... published by Elsevier, will feature new recommendations on late-onset hypogonadism (LOH), recently formulated by major scientific organizations. LOH is a ... symptoms and a deficiency in serum testosterone levels. Late-onset hypogonadism (LOH) is caused by a decline in gonadal production of androgens in males ...FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
... to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...
Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
... 2004, Dr. Hamdy was a Senior Principal Scientist at Watson Pharmaceuticals where he participated in an ANDA for testosterone gel for the treatment of hypogonadism that was approved 2005. He also participated in multiple INDs in oncology and autoimmune diseases leading to successful phase I and phase II ...Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
... markets products to treat overactive bladder, prostate cancer and central precocious puberty and is pursuing regulatory approval of drugs to treat hypogonadism and bladder cancer. Mr. Holveck noted, "In addition to the very successful drug, VANTAS(R), we are particularly excited about the opportunity to ...JCI online early table of contents: July 1, 2008
... and colleagues, at Massachusetts General Hospital, Boston, has identified mutations in the FGF8 gene in individuals with idiopathic hypogonadotropic hypogonadism (IHH), a disease characterized by failed sexual maturation and infertility due to a deficiency in the small protein gonadotropin-releasing hormone ...Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men
... Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, ... level is well-known for its association with osteoporosis, the impact of hypogonadism on overall physical functioning and fall risk has not been prospectively ...Hypogonadism in Medical Technology
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... in Europe and other territories. About hypogonadism Male hypogonadism is an increasingly recognized medical condition ... impair quality of life. Common effects of hypogonadism include decreased sexual desire, erectile ...Indevus Announces Submission of New Drug Application
... reported were comparable to other injectable hypogonadism treatments reported in the literature. There were ... Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical ...... 40-69 years, it is estimated that there are about 481,000 new cases of hypogonadism per year. Overall, approximately 2.4 million U.S. men suffer from the condition.(1) hypogonadism results from a deficiency in testosterone secretion that may occur ...
Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
... previously announced, are based on a Phase III study in which men with hypogonadism and low serum testosterone levels prior to entering the study were treated ... Schering Pharma AG, Germany in July 2005. About Hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 as an oral treatment for the symptoms of secondary hypogonadism and other conditions in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. ...
... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...
... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...
... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...
... endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical development. XIAFLEX(TM) (clostridial ...
... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...
Hypogonadism in Medical Definition
... Adrenal insufficiency ( Addison's disease ) - Hypoaldosteronism
Gonads
Polycystic ovary syndrome - 5-alpha-reductase deficiency - hypogonadism - Delayed puberty - Precocious puberty
Other
Autoimmune polyendocrine syndrome - Carcinoid syndrome - Laron syndrome - ...
Hypogonadism in Medical Dictionary
... Hypogonadotropic hypogonadism Alternative Names: Gonad otropin deficiency ; Kallmann syndrome ; Secondary hypogonadism Prevention : ... Male hypogonadism Types of testosterone therapy Several types of ...
... from secondary ( hypothalamic or pituitary) hypogonadism . Autonomic dysfunction may be associated with ... FSH levels may help determine if hypothalamic hypogonadism (low FSH ) or testicular factors (high FSH ) ... alcohol or heavy metals; (2) hypogonadotropic hypogonadism ( congenital or acquired)— idiopathic ...
... testes . This test is used to differentiate hypogonadism ( ovary or testes ) into primary hypogonadism (problem is with the ovary or testes ) or secondary hypogonadism (problem is with the pituitary gland or the ...
... Glaucoma ( Glaucoma ) Secondary Hyperparathyroidism Secondary hypogonadism (Hypogonadotropic hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , ...
... a deficiency or absence of endogenous testosterone : (1) primary hypogonadism ( congenital or acquired)—testicular failure due to ... ECG . Affected people may have abnormal genitalia ( cryptorchidism ), hypogonadism , or delayed puberty . ^ Top ... At birth , it remains up in the ...
... abnormally low testosterone levels - a medical condition called male hypogonadism . Testosterone should not be used if you are taking the supplement ... SEPA/ testosterone gel In clinical trials for the treatment of male hypogonadism . Combining testosterone gel with the SEPA absorption enhancer allows ...
... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...
... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...
... of ED cases. Between 35 and 50 percent of men with diabetes experience ED. Additional features in some cases include hypothyroidism , male hypogonadism , short stature and mild to moderate developmental delay and the complications of type 2 diabetes such as hyperlipidemia (high lipid s) and ...
... vasomotor symptoms associated with menopause , (2) treatment of vulva l and vagina l atrophy , (3) treatment of hypoestrogenism due to hypogonadism , castration , or primary ovarian failure, ... Possible side effects associated with chronic and prolonged use of topical corticosteroids ...
... from secondary ( hypothalamic or pituitary) hypogonadism . Autonomic dysfunction may be associated with ... FSH levels may help determine if hypothalamic hypogonadism (low FSH ) or testicular factors (high FSH ) ... alcohol or heavy metals; (2) hypogonadotropic hypogonadism ( congenital or acquired)— idiopathic ...
... testes . This test is used to differentiate hypogonadism ( ovary or testes ) into primary hypogonadism (problem is with the ovary or testes ) or secondary hypogonadism (problem is with the pituitary gland or the ...
... Glaucoma ( Glaucoma ) Secondary Hyperparathyroidism Secondary hypogonadism (Hypogonadotropic hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , ...
... a deficiency or absence of endogenous testosterone : (1) primary hypogonadism ( congenital or acquired)—testicular failure due to ... ECG . Affected people may have abnormal genitalia ( cryptorchidism ), hypogonadism , or delayed puberty . ^ Top ... At birth , it remains up in the ...
... abnormally low testosterone levels - a medical condition called male hypogonadism . Testosterone should not be used if you are taking the supplement ... SEPA/ testosterone gel In clinical trials for the treatment of male hypogonadism . Combining testosterone gel with the SEPA absorption enhancer allows ...
... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...
... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...
... of ED cases. Between 35 and 50 percent of men with diabetes experience ED. Additional features in some cases include hypothyroidism , male hypogonadism , short stature and mild to moderate developmental delay and the complications of type 2 diabetes such as hyperlipidemia (high lipid s) and ...
... vasomotor symptoms associated with menopause , (2) treatment of vulva l and vagina l atrophy , (3) treatment of hypoestrogenism due to hypogonadism , castration , or primary ovarian failure, ... Possible side effects associated with chronic and prolonged use of topical corticosteroids ...
Hypogonadism in Biological News
Study identifies pathway required for normal reproductive development
... of Medicine. The current study is the latest in a series of investigations by the MGH group into the genetic basis of idiopathic hypogonadotropic hypogonadism (IHH), a rare condition in which puberty does not take place naturally. IHH occurs when a structure in the brain called the hypothalamus fails to ...New licensing agreement to maximize AIDS drug development
... and South Korea. FortigelTM (testosterone gel), branded Tostrex® outside the United States, is marketed in Sweden for the treatment of male hypogonadism also by ProStrakan. Approvals of Rectogesic and Tostrex by the other member states of the European Union are being sought through the Mutual ...Hypogonadism in Biological Technology
QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference
... programs. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. QRX-431, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for lipid disorders and obesity. ...Hypogonadism in Biological Definition
... i.e. diabetes mellitus , thyroid disorders
Hypothalamic disorders, i.e. Kallmann syndrome
Hyperprolactinemia
Hypopituitarism
hypogonadism due to various causes
Psychological factors
Drugs, alcohol
Testicular factors
Genetic causes, e.g. Klinefelter syndrome
Neoplasm, ....
Other ContentsosteocyteoverlappingoverlappingoverlappingoverlappingoverlappingoverlappingoverhangoverhangoverhangoviductovulationovulationovulationovulationovulationoviductsOther TagsTraysTraysFlatFlatFlatFlatFlatMedMedMedMedMedMedMedMedMedSDSSDSZyagenIncubationOpticonArcturusLCMLCMOther Tagsmammary 2possession 2island 2island 3island 4specificity 2specificity 3
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)..., experts advise , , SATURDAY, Dec. 5 (Hea...ith allergies and asthma can have bad reactions to...al steps to prevent sneezing and wheezing, accordi...Immunology (ACAAI). , Those who are allergic to li...al plants, but both live and artificial trees can ...
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2[0] New Gene Findings Will Help Guide Treatment in Infant Leukemia[0] Keep Asthma, Allergies at Bay for the Holidays[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Intensive care units poorly equipped to care for the dying 58854 1Intensive care units poorly equipped to care for the dying 58854 2Fruit juices contain more vitamin C than their labels indicate 58852 1Fruit juices contain more vitamin C than their labels indicate 58852 2UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 1UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 2UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 3UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |